![[Podcast] Behind the Breakthroughs: How Almac Powers Clinical Trial Success with Care](https://imgproxy.divecdn.com/5lAJkli_KcGt1FSsw4EaegjgP76IHREqYEWbhNBJOXw/g:ce/rs:fit:770:435/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9CaW9QaGFybWFEaXZlXzEzNDZfeF83MjlfQXJ0d29yay5qcGc=.webp)
A front-line antiviral drug disappoints against worrisome monkeypox strain
Nature, Published online: 23 April 2025; doi:10.1038/d41586-025-01268-9Tecovirimat, which has been approved to treat mpox, was no better than a placebo in a large trial.
Nature, Published online: 23 April 2025; doi:10.1038/d41586-025-01268-9Tecovirimat, which has been approved to treat mpox, was no better than a placebo in a large trial.
